http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002513789-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-56 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
| filingDate | 1999-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2002-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2002513789-A |
| titleOfInvention | Fine particle size form of 1- (6-chloronaphth-2-ylsulfonyl) -4- [4- (4-pyridyl) benzoyl] piperazine |
| abstract | (57) [Summary]nThe present invention has pharmaceutically acceptable salts of 1- (6-chloronaphth-2-ylsulfonyl) -4- [4- (4-pyridyl) benzoyl] piperazine, and has antithrombotic and anticoagulant properties, and is therefore It relates to a fine particle size form of both the compound or a pharmaceutically acceptable salt thereof which is useful in a method of treating animals. The present invention also provides a method of preparing pharmaceutically acceptable salts and fine particle size forms of said compounds, pharmaceutical compositions containing them, and the preparation of medicaments for use in generating antithrombotic or anticoagulant effects in humans. It also relates to their use in |
| priorityDate | 1998-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 63.